|
Originally published In Press as doi:10.1074/jbc.M504489200 on February 6, 2006
J. Biol. Chem., Vol. 281, Issue 14, 9482-9489, April 7, 2006
1,4-Galactosyltransferase V Functions as a Positive Growth Regulator in Glioma*
Jianhai Jiang,
Xiaoning Chen,
Jialin Shen,
Yuanyan Wei,
Tao Wu,
Yanzhong Yang,
Hanzhou Wang,
Hongliang Zong,
Junwu Yang,
Si Zhang,
Jianhui Xie,
Xiangfei Kong,
Weicheng Liu, and
Jianxin Gu1
From the
Key Laboratory of Medical Molecular Virology Ministry of Education and Health, Gene Research Center, Shanghai Medical College of Fudan University (former Shanghai Medical University), Shanghai 200032, China
1,4-galactosyltransferase V (GalT V; EC 2.4.1.38
[EC]
) can effectively galactosylate the GlcNAc 1 6Man arm of the highly branched N-glycans that are characteristic of glioma. Previously, we have reported that the expression of GalT V is increased in the process of glioma. However, currently little is known about the role of GalT V in this process. In this study, the ectopic expression of GalT V could promote the invasion and survival of glioma cells and transformed astrocytes. Furthermore, decreasing the expression of GalT V in glioma cells promoted apoptosis, inhibited the invasion and migration and the ability of tumor formation in vivo, and reduced the activation of AKT. In addition, the activity of GalT V promoter could be induced by epidermal growth factor, dominant active Ras, ERK1, JNK1, and constitutively active AKT. Taken together, our results suggest that GalT V functioned as a novel glioma growth activator and might represent a novel target in glioma therapy.
Received for publication, April 25, 2005
, and in revised form, February 3, 2006.
* This work was supported by the 863 Program of China (2001AA234031) and the National Natural Scientific Foundation of China (30330320) and a grant from the development of science and technology of Shanghai (02DJ14002). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed. Tel.: 86-21-54237704; Fax: 86-21-64164489; E-mail: jxgu{at}shmu.edu.cn.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Wei, D. Liu, Y. Ge, F. Zhou, J. Xu, H. Chen, J. Gu, and J. Jiang
Identification of E1AF as a Target Gene of E2F1-induced Apoptosis in Response to DNA Damage
J. Biochem.,
October 1, 2008;
144(4):
539 - 546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhou, Y. Wei, D. Liu, X. Ge, F. Zhou, X. Yun, J. Jiang, and J. Gu
Identification of {beta}1,4GalT II as a Target Gene of p53-mediated HeLa Cell Apoptosis
J. Biochem.,
April 1, 2008;
143(4):
547 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jiang, Y. Wei, J. Shen, D. Liu, X. Chen, J. Zhou, H. Zong, X. Yun, X. Kong, S. Zhang, et al.
Functional Interaction of E1AF and Sp1 in Glioma Invasion
Mol. Cell. Biol.,
December 15, 2007;
27(24):
8770 - 8782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sato and K. Furukawa
Sequential Action of Ets-1 and Sp1 in the Activation of the Human beta-1,4-Galactosyltransferase V Gene Involved in Abnormal Glycosylation Characteristic of Cancer Cells
J. Biol. Chem.,
September 21, 2007;
282(38):
27702 - 27712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jiang, J. Shen, T. Wu, Y. Wei, X. Chen, H. Zong, S. Zhang, M. Sun, J. Xie, X. Kong, et al.
Down-regulation of {beta}1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells
Glycobiology,
November 1, 2006;
16(11):
1045 - 1051.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|